Abstract
Background: Blood pressure measurement is one of the most performed procedures in clinical practice. This narrative review aims to expose the relevant aspects surrounding the definition of arterial hypertension, the historical path of its treatment, and the contribution of studies to the decrease in mortality due to cardiovascular disease over time. Methodology: Narrative review of the history of arterial hypertension from recognizing high blood pressure as a factor associated with cardiovascular risk to the historical evolution of treatment up to the SPRINT study published in 2015. Results: Until about 50 years ago, arterial hypertension was known as an essential pathology; this condition was not always considered a disease. The discovery of blood pressure has been attributed to Stephen Hales, a poet, orator and priest born in England. The first measurement of blood pressure and incidentally pulse pressure was made in 1733 in animals. The origin of blood pressure, arterial hypertension, and the path travelled for recognizing this condition as a disease and later its treatment until reaching the SPRINT study in 2015, which demonstrated the benefit of reducing the target systolic blood pressure figure in a non-diabetic population. Conclusion: This narrative review demonstrates that the recognition of high blood pressure as a cardiovascular risk factor allowed progress in scientific research to determine the treatment and blood pressure figures that favor the reduction of mortality and morbidity from this cause.
References
Organización Mundial de la Salud [Internet]. Ginebra: OMS; c2021. Hipertensión. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/hypertension
Cooper H, Hedges L, Valentine J. The handbook of research synthesis and meta- analysis. 3 ed. New York: Russell Sage Foundation; 2019.
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ [Internet]. 2015; 350: g7647. doi: https://doi.org/10.1136/bmj.g7647
Day RA. Cómo escribir y publicar trabajos científicos. 3 ed. Washington, D.C.: Organización Panamericana de la Salud; 2005. Disponible en: https://www3.paho.org/hq/dmdocuments/comoescribir- escritos-cientificos-2010.pdf
JBI [Internet]. Critical appraisal tools. Consultada en marzo 2021. Disponible en: https://jbi.global/critical-appraisal-tools
Saklayen MG, Deshpande NV. Timeline of history of hypertension treatment. Front Cardiovasc Med [Internet]. 2016; 3. doi: https://doi.org/10.3389/fcvm.2016.00003
Booth J. A short history of blood pressure measurement. Proc R Soc Med. 1977; 70(11): 793-799.
Esunge PM. From blood pressure to hypertension: the history of research. J R Soc Med [Internet]. 1991; 84(10): 621. doi: 10.1177/014107689108401019
O’Rourke MF. Frederick Akbar Mahomed. Hypertension [Internet]. 1992; 19(2): 212-217. doi: https://doi.org/10.1161/01.HYP.19.2.212
Cameron JS, Hicks J. Frederick Akbar Mahomed and his role in the description of hypertension at Guy’s Hospital. Kidney Int [Internet]. 1996; 49(5): 1488-1506. doi: https://doi.org/10.1038/ki.1996.209
Moser M. Historical perspectives on the management of hypertension. J Clin Hypertens (Greenwich) [Internet]. 2006; 8(2): 15-20. doi: https://doi.org/10.1111/j.1524-6175.2006.05836.x
Effects of treatment on morbidity in hypertension. results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA [Internet]. 1967; 202(11): 1028–1034. doi: https://doi.org/10.1001/jama.1967.03130240070013
Effects morbidity of treatment on in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA [Internet]. 1970; 213(7): 1143–1152. doi: https://doi.org/10.1001/jama.1970.03170330025003
Five-year findings of the hypertension detection and follow-up program: I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA [Internet]. 1979; 242(23): 2562–2571. doi: https://doi.org/10.1001/jama.1979.03300230018021
Multiple risk factor intervention trial: Risk factor changes and mortality results. multiple risk factor intervention trial research group. JAMA [Internet]. 1982; 248(12): 1465–1477. doi: https://doi.org/10.1001/jama.1982.03330120023025
MRC trial of treatment of mild hypertension: principal results. Medical research council working party. Br Med J (Clin Res Ed) [Internet]. 1985; 291(6488): 97-104. doi: https://doi.org/10.1136/bmj.291.6488.97
Amery A, Birkenhäger W, Brixko P, Bulpitt C, Clement D, de Leeuw P, et al. Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years. European Working Party on High blood pressure in the Elderly (EWPHE) results: sub-group analysis on entry stratification. J Hypertens Suppl. 1986; 4(6): 642-647.
Staessen J, Bulpitt C, Clement D, De Leeuw P, Fagard R, Fletcher A, et al. Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. BMJ [Internet]. 1989; 298(6687): 1552-1156. doi: https://doi.org/10.1136/bmj.298.6687.1552
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final Results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA [Internet]. 1991; 265(24): 3255–3264. doi: https://doi.org/10.1001/jama.1991.03460240051027
Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of mild hypertension study: Final results. JAMA [Internet]. 1993; 270(6): 713–724. doi: https://doi.org/10.1001/jama.1993.03510060059034
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med [Internet]. 1997; 336(16): 1117-1124. doi: https://doi.org/10.1056/NEJM199704173361601
Cappuccio FP, Markandu ND, Carney C, Sagnella GA, MacGregor GA. Double-blind randomised trial of modest salt restriction in older people. Lancet [Internet]. 1997; 350(9081): 850-854. doi: https://doi.org/10.1016/S0140-6736(97)02264-2
Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet [Internet]. 1998; 351(9118): 1755-1762. doi: https://doi.org/10.1016/s0140-6736(98)04311-6
UK prospective diabetes study group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ [Internet]. 1998; 317(7160): 317-703. doi: https://doi.org/10.1136/bmj.317.7160.703
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK Trial. JAMA [Internet]. 2006; 295(23): 2726. doi: https://doi.org/10.1001/jama.295.23.2726-c
Staessen J, Bulpitt C, Clement D, De Leeuw P, Fagard R, Fletcher A, et al. Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. BMJ [Internet]. 1989; 298(6687): 1552-1556. doi: https://www.jstor.org/stable/29704291
ALLHAT officers and coordinators for the ALLHAT Collaborative Research Group. The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA [Internet]. 2002; 288(23): 2981-2997. doi: https://doi.org/10.1001/jama.288.23.2981
Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. Second Australian National Blood pressure study group. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med [Internet]. 2003; 348(7): 583- 592. doi: https://doi.org/10.1056/NEJMoa021716
The SPRINT research group. A Randomized trial of intensive versus standard blood-pressure control. N Engl J Med [Internet]. 2015; 373(22): 2103-2116. doi: https://doi.org/10.1056/NEJMoa1511939
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Mayut Delgado-Galeano